A Study Investigating the Safety, Tolerability, Drug Levels and Drug Effect of BMS-986278 in Healthy Adult Participants (Part 1) and Japanese Participants (Part 2)
Clinical trial NCT05684289 · COMPLETED
Trial details
- NCT number
- NCT05684289
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-03
- Primary completion
- 2023-05-02
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.